NF1P9

Across TCGA pan-cancer cohorts, NF1P9 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated NF1P9 data layer compared with 1 for mutation status.

The strongest signal is observed in uveal melanoma (UVM), where higher NF1P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NF1P9 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LIHC show a favorable association.

UVM, COAD, and KIRC are the cancer types where NF1P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.288	0.864	<.001	108	view →
COAD	OS	Tertile	All	0.163	0.869	<.001	108	view →
KIRC	DFS	Tertile	III,IV	0.211	0.494	.002	66	view →
MESO	OS	Tertile	All	0.144	0.557	.029	45	view →
KIRP	OS	Tertile	All	0.163	0.708	<.001	36	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
ESCA	OS	Tertile	II,III,IV	0.505	0.743	.002	28	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
PCPG	DFS	Tertile	All	0.121	0.778	.001	27	view →
THYM	DFS	Tertile	II,III,IV	0.681	0.885	.014	24	view →
CESC	DFS	Tertile	All	0.702	0.827	.017	24	view →
TGCT	DFS	Tertile	II,III,IV	0.526	0.951	.011	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

NF1P9–UVM (OS)

Open the UVM breakdown →